The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
analysts adjust ratings and price targets for several european companies
Securities analysts have revised ratings and price targets for several European companies. Notable changes include JP Morgan raising Lloyds' target price to 62p and upgrading Societe Generale to overweight, while Citigroup increased Verbund's target to EUR 64. Other adjustments include Stifel raising Vusiongroup's target to EUR 215 and UBS cutting KGaA's target to EUR 28.2.
analysts update recommendations and price targets for major european companies
Analysts have updated their recommendations for several companies, with notable changes including Accor's price target raised to EUR 54 and Legrand upgraded to buy with a target of EUR 125. UBS Group was downgraded to underperform, while Renault's target increased to EUR 68. Other adjustments include Michelin and Ipsen, both seeing target revisions.
Swiss stock market rises as Kühne Nagel and UBS lead gains
The Swiss stock market closed higher on Monday, with the SMI index surpassing 12,000 points for the first time since late October, despite a cautious trading environment ahead of Donald Trump's inauguration. Kühne + Nagel, Lonza, and UBS were among the top gainers, while Zurich and Schindler saw declines. The VSMI volatility index rose by 6.5%, indicating expectations of increased market fluctuations.
analysts update recommendations and price targets for key european stocks
Analysts have made several notable recommendations, including JP Morgan maintaining an Underweight rating for Adecco with a reduced target of CHF 19.60, while Air France-KLM was downgraded by Barclays to Underweight with a target of EUR 7. ArgenX received a buy rating from HC Wainwright & Co, raising its target to 717 USD, and BioMérieux was upgraded to Outperform by Oddo BHF with a target of EUR 132. Other significant changes include upgrades for Deliveroo and Orange, while OVH Groupe remains a sell with a raised target of EUR 8.50.
swiss small and mid caps show resilience amid economic challenges
Swiss small and mid-cap companies present intriguing opportunities for portfolio diversification, particularly in sectors like medtech, which has outpaced the Swiss economy with 6% growth over the past decade. While some sectors face challenges, such as food and automotive, others, especially those linked to artificial intelligence and pharmaceuticals, are thriving. Current valuations in this segment are below historical averages, indicating potential for growth despite a seemingly unfavorable environment.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.